"Disclaimer: Spotee and/or its directors, employees, representatives and associates hold an interest in Exopharm." - A strong indication for the quality of EX1. Just be patient I believe good things will come and if you do really good research you will see why.
Ann: September Quarterly Report and Appendix 4C, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.87M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4139 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 107354 | 1 |
View Market Depth
| Last trade - 09.02am 02/09/2024 (20 minute delay) ? |
| TYP (ASX) Chart |
Day chart unavailable